Effects of Extra-fascial Interscalene Brachial Plexus Block on Diaphragmatic Function in School-Aged Children
1 other identifier
interventional
72
1 country
1
Brief Summary
The traditional intra-fascial interscalene brachial plexus block (ISB) is already one of the routine anesthesia methods for pediatric upper limb surgeries in clinical practice. This study aims to clarify the effect of the extra-fascial interscalene brachial plexus block on the diaphragm function of school-age children, as well as its analgesic effect, and to compare it with the traditional intra-fascial ISB. It intends to explore a more effective and safer ISB method for children. With the aim of optimizing techniques and accurately evaluating, to balance the benefits of analgesia and safety, and thereby promoting the development of precise pediatric anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
February 3, 2026
January 1, 2026
9 months
January 26, 2026
January 31, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the rate of diaphragmatic paralysis using ultrasound.
From enrollment to the end of treatment at 2-3 days
Study Arms (2)
intra-fascial interscalene brachial plexus block (ISB)
PLACEBO COMPARATORextra-fascial interscalene brachial plexus block (ISB)
EXPERIMENTALInterventions
Perform an intra-fascial interscalene brachial plexus block by penetrating the brachial plexus fascia and injecting 0.5 ml/kg of 0.2% ropivacaine.
Perform an extra-fascial interscalene brachial plexus block, positioning the needle tip 2-4 mm lateral to the brachial plexus sheath, at a level equidistant between the C5 and C6 roots, measured using the on-screen caliper tool. Inject 0.5 ml/kg of 0.2% ropivacaine for nerve blockade.
Eligibility Criteria
You may qualify if:
- Age range: School-aged children (6-12 years old).
- Type of surgery: Upper limb surgery.
- ASA classification: Grades I-II.
You may not qualify if:
- Infection, anatomical deformity, or tumor at the puncture site.
- Coagulation disorders (INR \> 1.4, platelet count \< 100 × 10⁹/L).
- History of allergy to local anesthetics (ropivacaine).
- Severe cardiopulmonary or neurological diseases (e.g., epilepsy, myopathy).
- Pre-existing ipsilateral phrenic nerve paralysis or Horner syndrome.
- Preoperative long-term use of analgesics (which may affect efficacy assessment).
- Parent or child refusal to participate in the study.
- Emergency surgery or inability to cooperate with assessments (e.g., severe developmental delay).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Sixth People's Hospital
Shanghai, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- anesthesiologist
Study Record Dates
First Submitted
January 26, 2026
First Posted
February 2, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
February 3, 2026
Record last verified: 2026-01